Experience the new nddHub
ndd Medical Technologies

Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial

2018 The Lancet Respiratory Medicine https://doi.org/10.1016/S2213-2600(18)30181-4

Authors

Toby M Maher, Ellen M van der Aar, Olivier Van de Steen, Lisa Allamassey, Julie Desrivot, Sonia Dupont, Liesbeth Fagard, Paul Ford, Ann Fieuw, Wim Wuyts

Study site (country)

Indications

ndd products mentioned in this publication

Easy on-PC

Easy on-PC

PC spirometer


Other publications by indication

Take the next step
Don't miss what's next!

Exclusive offers, updates, and more.

Sign up today!